[Cytostatics and immunosuppressive agents in dermatology].
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D003882:Dermatomyositis / Q000188:drug therapy; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007636:Keratoacanthoma / Q000188:drug therapy; D007642:Keratosis / Q000188:drug therapy; D007971:Leukoplakia / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D008206:Lymphatic Diseases / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D009182:Mycosis Fungoides / Q000188:drug therapy; D010212:Papilloma / Q000188:drug therapy; D010392:Pemphigus / Q000188:drug therapy; D011230:Precancerous Conditions / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy; D011711:Pyoderma / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents
Cytostatica und Immunosuppressiva in der Dermatologie.